Adolor Corp. (ADLR) Stock Quote

Detailed Quote for Adolor Corp. (ADLR)

close 52 Week Information

52 Week High

December 9, 2011

Close: 4.83

52 Week Low

December 23, 2010

Close: 1.14

Today

5d

1m

3m

1y

more

Last Price
N/A

Change $
N/A

Change %
N/A

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
N/A

High
N/A

Low
N/A

Prev Close
N/A

Last Trade
N/A

Volume
0

52 Wk Hi
4.83

52 Wk Low
1.14

Market Cap
N/A

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
46,601,704

EPS (TTM)
-0.08

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Adolor Corp. (ADLR)

Sector News | Topic News

News for ADLR

Wed, Dec 07, 2011

7:00 AM

Cubist Pharmaceuticals Announces Results of Initial Tender Offer for Outstanding Shares of Adolor Corporation and Commencement of Subsequent Offering Period - Business Wire

Tue, Nov 15, 2011

8:53 AM

Cubist Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Adolor - Business Wire

Tue, Oct 25, 2011

9:00 AM

Analyst View, Impact of Global Events - Research Report on Cray Inc. and Adolor Corporation - Marketwire

Mon, Oct 24, 2011

1:22 PM

The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Adolor Corp. in Connection With the Sale of the Company to Cubist Pharmaceuticals Inc. - PR Newswire

More News for ADLR >>

Tags for Adolor Corp.

Research stocks or mutual funds related to Adolor Corp. by keywords or tags. Find companies that have a similar focus to ADLR. The keywords below have been associated to ADLR by either user submission or electronic means.

pharmaceutical intermediate pharmaceutical courses biotech research pharmaceutical branding pharmaceutical market pharmaceuticals companies generic pharmaceutical jobs in pharmaceutical pharmaceutical training pharmaceutical research and development pharmaceutical supplies pharmaceutical manufacturing company pharma marketing pharma manufacturing pharmaceuticals jobs pharma license novartis pharmaceuticals gmp pharmaceutical or careers pharmaceutical class pharmaceutical ingredients active pharmaceutical ingredient pharmaceutical cro active pharmaceutical ingredients r&d manufacturing pharmaceutical sales pharma pharmaceutical distributors consumer credit corporation biotech corporation pharmaceutical reports pharmaceutical production pharmaceutical consultant biotech biotechnology research Drugs animal health careers pharma r&d pharmaceutical manufacturing software biotechnology careers pharmaceutical manufacturing pharmaceutical formulation adolor pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting a career in pharmaceutical sales pharmaceutical industry pharmaceutical market analysis

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.